Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease

dc.contributor.authorSánchez Danés, Adriana
dc.contributor.authorRichaud-Patin, Yvonne
dc.contributor.authorCarballo Carbajal, Iria
dc.contributor.authorJiménez Delgado, Senda
dc.contributor.authorCaig, Carles
dc.contributor.authorMora, Sergio
dc.contributor.authorDi Guglielmo, Claudia
dc.contributor.authorEzquerra Trabalón, Mario
dc.contributor.authorPatel, Bindiben
dc.contributor.authorGiralt Torroella, Albert
dc.contributor.authorCanals i Coll, Josep M.
dc.contributor.authorMemo, Maurizio
dc.contributor.authorAlberch i Vié, Jordi, 1959-
dc.contributor.authorLópez Barneo, José
dc.contributor.authorVila Farré, Miquel
dc.contributor.authorCuervo, Ana Maria
dc.contributor.authorTolosa, Eduardo
dc.contributor.authorConsiglio, Antonella
dc.contributor.authorRaya Chamorro, Ángel
dc.date.accessioned2019-05-24T16:19:00Z
dc.date.available2019-05-24T16:19:00Z
dc.date.issued2012-05
dc.date.updated2019-05-24T16:19:00Z
dc.description.abstractInduced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in relevant cell types, but it is unclear whether they could successfully model age-related diseases such as Parkinson's disease (PD). Here, we generated iPSC lines from seven patients with idiopathic PD (ID-PD), four patients with familial PD associated to the G2019S mutation in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene (LRRK2-PD) and four age- and sex-matched healthy individuals (Ctrl). Over long-time culture, dopaminergic neurons (DAn) differentiated from either ID-PD- or LRRK2-PD-iPSC showed morphological alterations, including reduced numbers of neurites and neurite arborization, as well as accumulation of autophagic vacuoles, which were not evident in DAn differentiated from Ctrl-iPSC. Further induction of autophagy and/or inhibition of lysosomal proteolysis greatly exacerbated the DAn morphological alterations, indicating autophagic compromise in DAn from ID-PD- and LRRK2-PD-iPSC, which we demonstrate occurs at the level of autophagosome clearance. Our study provides an iPSC-based in vitro model that captures the patients' genetic complexity and allows investigation of the pathogenesis of both sporadic and familial PD cases in a disease-relevant cell type.
dc.format.extent16 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec615356
dc.identifier.issn1757-4676
dc.identifier.pmid22407749
dc.identifier.urihttps://hdl.handle.net/2445/133843
dc.language.isoeng
dc.publisherEMBO Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/emmm.201200215
dc.relation.ispartofEMBO Molecular Medicine, 2012, vol. 4, num. 5, p. 380-395
dc.relation.urihttps://doi.org/10.1002/emmm.201200215
dc.rights(c) EMBO, 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationDopamina
dc.subject.classificationMetabolisme
dc.subject.classificationFenotip
dc.subject.classificationGenètica
dc.subject.classificationNeurones
dc.subject.classificationMalaltia de Parkinson
dc.subject.classificationPatologia
dc.subject.classificationCèl·lules mare
dc.subject.otherDopamine
dc.subject.otherMetabolism
dc.subject.otherPhenotype
dc.subject.otherGenetics
dc.subject.otherNeurons
dc.subject.otherParkinson's disease
dc.subject.otherPathology
dc.subject.otherStem cells
dc.titleDisease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
615356.pdf
Mida:
1.58 MB
Format:
Adobe Portable Document Format